GlaxoSmithKline
Investigational varicella vaccine
Chickenpox
Countdown
139days
Phase 3 readout · Nov 23, 2026
What's at stake
Phase 3 trial results for Investigational varicella vaccine in Chickenpox are due Nov 23, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 14h ago
“CT.gov NCT06693895: Phase 3 trial, sponsor GlaxoSmithKline, drug Investigational varicella vaccine. Primary completion date 2026-11-23 (estimated).”